J Endod:全覆盖修复后根管治疗的发生率:一项10年的回顾性研究

2020-04-09 lishiting MedSci原创

采用冠修复牙齿的过程会引起很多牙髓激惹的机会。这篇研究的目的是为了评估和分析单单位全覆盖冠修复后导致非手术根管治疗(NS-RCT)发生的因素。

采用冠修复牙齿的过程会引起很多牙髓激惹的机会。这篇研究的目的是为了评估和分析单单位全覆盖冠修复后导致非手术根管治疗(NS-RCT)发生的因素。

研究从Delta Dental of Wisconsin保险数据库中搜寻并分析了2008-2017年间共88,409例冠修复病例的保险索赔资料。采用Cox regression model分析预测变量对存留牙齿的影响。不利事件基于口腔操作和命名代码定义为NS-RCT、牙齿拔除、根管再治疗或根尖切除术。

结果显示,在88,409例冠修复中,8.97%为全金属冠修复,41.40%为全瓷冠修复, 49.64%为烤瓷熔附金属冠修复(PFM)。所有戴冠牙齿9年后的存留率为90.41%。NS-RCT为最常发生的不利事件。PFM冠发生不利事件较全金属冠高,较全瓷冠低。50岁以下戴冠个体发生不利事件的几率高于50岁以上的个体。

结论:冠修复后牙髓治疗的风险较低。这个风险随着全瓷或PFM修复以及患者年龄降低而增加。

原始出处:

Abby Yavorek, Pradeep Bhagavatula., et al. The Incidence of Root Canal Therapy After Full-Coverage Restorations: A 10-Year Retrospective Study. J Endod., 2020 Mar 29[Online ahead of print]

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826594, encodeId=97ca182659438, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Jan 03 11:24:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066294, encodeId=86f22066294c5, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Oct 22 16:24:52 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523020, encodeId=52af152302034, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585701, encodeId=ea3d1585e0111, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1826594, encodeId=97ca182659438, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Jan 03 11:24:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066294, encodeId=86f22066294c5, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Oct 22 16:24:52 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523020, encodeId=52af152302034, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585701, encodeId=ea3d1585e0111, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1826594, encodeId=97ca182659438, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Jan 03 11:24:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066294, encodeId=86f22066294c5, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Oct 22 16:24:52 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523020, encodeId=52af152302034, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585701, encodeId=ea3d1585e0111, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1826594, encodeId=97ca182659438, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Jan 03 11:24:52 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2066294, encodeId=86f22066294c5, content=<a href='/topic/show?id=978c2966046' target=_blank style='color:#2F92EE;'>#全覆盖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29660, encryptionId=978c2966046, topicName=全覆盖)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Oct 22 16:24:52 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523020, encodeId=52af152302034, content=<a href='/topic/show?id=c72462241ff' target=_blank style='color:#2F92EE;'>#根管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62241, encryptionId=c72462241ff, topicName=根管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba5e11492705, createdName=zhaozhouchifen, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1585701, encodeId=ea3d1585e0111, content=<a href='/topic/show?id=e76840556f9' target=_blank style='color:#2F92EE;'>#回顾性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40556, encryptionId=e76840556f9, topicName=回顾性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037917278808, createdName=jiyangfei, createdTime=Sat Apr 11 12:24:52 CST 2020, time=2020-04-11, status=1, ipAttribution=)]

相关资讯

J Endod:非手术牙髓治疗的5年存留率:一项队列调查

这项基于种群研究的目的是为了调查接受非手术牙髓治疗牙齿的5年存留率。特别是分析影响牙髓治疗牙齿5年存留率的变量。

J Endod:经历根管治疗或牙齿拔除患者的生命质量调查

对于以患者为中心的涉及根管治疗后对日常生活影响的治疗效果所知甚少。当有假体可以置换的时候,治疗多选择拔除患牙。这篇研究的目的是通过评估根管治疗对生命质量和质量调整生命年(QALY)的影响以更加了解患者的观点,并与经历拔牙的患者进行比较。

AP&T:静脉注射与口服铁治疗急性胃肠道出血后贫血的治疗效果

急性胃肠道出血是普遍存在的情况,缺铁性贫血是常见的并发症。本项研究旨在比较静脉铁羧基麦芽糖(FCM)和口服硫酸亚铁(FeSulf)在治疗非静脉曲张性消化道出血继发贫血患者的疗效和安全性

J Endod:患者根管治疗后持续疼痛的3年疗效观察分析

这篇研究的目的是为了评估患者根管治疗(RCT)后6个月存在持续疼痛的长期疗效,并评估不同患者疼痛迁延的特点。

J Endod:隐裂恒后牙牙髓治疗后的疗效和存留情况:一项系统性文献回顾和meta分析

这篇系统性文献回顾和meta分析的目的是为了评估隐裂后牙牙髓治疗的成功率和存留率,并评估能够影响牙齿存留的术前因素。

J Endod:偏倚风险和它的干预作用对牙髓疾病随机对照试验评估的影响

这篇研究的目的是为了评估近期出现在牙髓疾病中的随机对照试验(RCTs)所采用的方法质量并检测方法学特征对治疗效果影响的程度。